首页|超声引导下粗针穿刺活检对甲状腺TI-RADS 4a类结节良恶性的鉴别诊断价值

超声引导下粗针穿刺活检对甲状腺TI-RADS 4a类结节良恶性的鉴别诊断价值

扫码查看
目的 探讨超声引导下粗针穿刺活检(US-CNAB)对甲状腺TI-RADS 4a类结节良恶性的鉴别诊断价值。方法 选取2021-02-2023-01 于郑州大学第二附属医院行US-CNAB的 119 例共 142 个甲状腺TI-RADS 4a类结节患者,以术后常规病理检查为"金标准",评价US-CNAB鉴别诊断甲状腺TI-RADS 4a类结节良恶性的效能,统计并发症发生率。结果 US-CNAB结果与术后常规病理结果的差异无统计学意义(P>0。05)。以术后常规病理检查为"金标准",US-CNAB鉴别诊断甲状腺TI-RADS 4a类结节良恶性的准确度、灵敏度、特异度、阳性预测值、阴性预测值分别为 98。15%、88。24%、95。78%、96。36%93。75%。US-CNAB后出现声音嘶哑 1 例,血肿6 例,并发症发生率为5。88%。结论 US-CNAB对鉴别甲状腺TI-RADS 4a类结节的良恶性具有较高的诊断价值。
Diagnosis value of ultrasound-guided core-needle aspiration biopsy in differential benign and malignant thyroid TI-RADS 4a nodules
Objective To investigate the value of ultrasound-guided core-needle aspiration biopsy(US-CNAB)in the differential diagnosis of benign and malignant thyroid TI-RADS 4a nodules.Methods A total of 142 patients with thyroid TI-RADS 4a nodules who un-derwent US-NAB in the Second Affiliated Hospital of Zhengzhou University from Feb.2021 to Jan.2023 were enrolled to evaluate the efficacy of US-CNAB in the differential diagnosis of benign and malignant thyroid TI-RADS 4a nodules with routine postoperative pathological exami-nation as the"gold standard",and the incidence of complications was statistically calculated.Results There was no significant difference be-tween the results of US-CNAB and the routine pathological results after surgery(P>0.05).The accuracy,sensitivity,specificity,positive predictive value,and negative predictive value of US-CNAB in the differential diagnosis of benign and malignant thyroid TI-RADS 4a nodules were 98.15%,88.24%,95.78%,96.36%,and 93.75%,respectively.After US-CNAB,there was hoarseness and hematoma in 1 case,and the complication rate was 5.88%.Conclusion US-CNAB has a high diagnostic value in differentiat benign and malignant thyroid TI-RADS 4a nodules.

Ultrasound-guidedCore-needle aspiration biopsyTI-RADS 4a nodules of thyroid gland

张晓光、卢学峰、喻红霞

展开 >

郑州大学第二附属医院超声科 郑州 450014

超声引导 粗针穿刺活检 甲状腺TI-RADS 4a结节

2024

河南外科学杂志
郑州大学

河南外科学杂志

影响因子:0.709
ISSN:1007-8991
年,卷(期):2024.30(2)
  • 14